Status:
COMPLETED
Resistance Exercise Training For Radically Treated Respiratory Cancer
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Agentschap voor Innovatie door Wetenschap en Technologie
Conditions:
Respiratory Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The first part of the study is an observational part. In eligible patients with early stage respiratory cancer, the primary and secondary endpoints will be evaluated before and after their scheduled r...
Eligibility Criteria
Inclusion
- Patients with non-small cell or small cell lung cancer or mesothelioma candidate for radical treatment
- either by surgical resection with or without perioperative chemotherapy
- or by thoracic radiotherapy with or without chemotherapy
- Between 18 and 80 years of age
- Written informed consent
- Supplementary criteria for PART II:
- Treatment for their cancer considered radical
- either by surgical resection with or without perioperative chemotherapy
- or by thoracic radiotherapy with or without chemotherapy
- having less than 70% of the predicted normal value of the Quadriceps Force (QF) or a decrease of more than 10% predicted value of the QF between the baseline and post-radical therapy measurement of QF
- Post treatment assessment maximum 14 days after radical treatment or between 6th and 8th week after radical treatment if the latter consists only of surgical resection
Exclusion
- Patients presenting with one or more of the following will be excluded:
- Severe anemia (Hb below 8 g/dl)
- Fever (\> 38°C)
- Cachexia (loss of more than 35% of premorbid weight)
- Severe cardiac, neurological and orthopedic co-morbidity interfering with exercise training.
- A pacemaker, hip, knee of shoulder prosthesis or recently introduced spirals, metal pens, bolts or plates
- Uncontrolled diabetes, epilepsy or migraine
- Uncontrolled vertebral diseases (osteoporotic or metastatic fractures, acute hernia, discopathy, spondylitis)
- Open wounds
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT00752700
Start Date
January 1 2009
End Date
July 1 2012
Last Update
December 5 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ St. Jan
Bruges, Belgium, 8000
2
CHU Saint Pierre
Brussels, Belgium
3
University Hospital Ghent
Ghent, Belgium, 9000
4
CHU Sart Tilman
Liège, Belgium, 4000